Improved treatment strategies reduce the increased mortality risk in early RA patients
Open Access
- 9 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (11), 2210-2216
- https://doi.org/10.1093/rheumatology/keq250
Abstract
Objective. A higher mortality rate in patients with RA than in the general population has been reported in most series. Treatment strategies for RA have improved dramatically over the last decades, resulting in less inflammation and joint damage. We investigated whether this change in treatment corresponds to reversal of excess mortality by studying a large inception cohort of early RA patients exposed to different treatment strategies. Methods. Six hundred and eighty-four RA patients included in the Leiden Early Arthritis Clinic between 1993 and 2008 were studied. Treatment was different for three inclusion periods. From 1993 to 1995 patients were treated with NSAIDs and only late in their disease with DMARDs. From 1996 to 1998 patients were promptly treated with HCQ or SSZ. From 1999 to 2008 patients were immediately treated with MTX monotherapy or in combination with other disease-modifying drugs. Life/death status was tracked nationally using the civic registries. Mortality rates were compared with the general Dutch population. Results. In Periods 1 and 2, increased standardized mortality rates were found, 1.35 (95% CI 0.94, 1.93) and 1.23 (95% CI 0.91, 1.67), respectively, while a decreased standardized mortality rate was found for patients included in 1999–2006 [0.49 (95% CI 0.31, 0.77)]. Age of onset [hazard ratio (HR) 1.10 (95% CI 1.07, 1.13)], erosive disease [HR 2.03 (95% CI 1.22, 3.37)], high CRP level [HR 1.09 (95% CI 1.01, 1.18)], smoking [HR 2.39 (95% CI 1.31, 4.38)] and higher baseline HAQ score [HR 1.53 (95% CI 1.06, 2.20)] associated with mortality. Conclusion. Current treatment strategies for early RA, such as that given in inclusion Period 3, might contribute to the reversal of excess mortality in RA.Keywords
This publication has 16 references indexed in Scilit:
- Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United StatesRheumatology, 2008
- Comparison of Treatment Strategies in Early Rheumatoid ArthritisAnnals of Internal Medicine, 2007
- Rheumatoid arthritis: the goal rather than the health-care provider is keyThe Lancet, 2006
- Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985Arthritis & Rheumatism, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2004
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritisArthritis & Rheumatism, 2000
- Multiple imputation of missing blood pressure covariates in survival analysisStatistics in Medicine, 1999
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988